Marina Cunha Remains Busy and Active After Traveling to China for Blue Horizon Stem Cell Treatments

By: PRLog
PRLog - Jul. 21, 2014 - NEW YORK -- Busy hands are happy hands and Marina Cunha couldn’t agree more. The active fashion designer, who originally hails from Goias, Brazil, spends her days living up to that old adage. For the last 20 years, Ms. Cunha has worked and lived in the New York City area raising her family and enjoying an array of activities including cooking, baking, and most of all spending time with her children and grandson.

Ms. Cunha’s profession and her hobbies keep her hands very busy, but over the last few years, she began to experience constant pain in her joints, neck, and back.  “The pain in my hands was overpowering and as a result my productivity at home and work was compromised,” said Ms. Cunha. After conventional treatments did little to relieve her discomfort, Ms. Cunha sought a more innovative approach to manage her pain.

Stem cell guru Brian Mehling, M.D., founder and chief medical officer of Blue Horizon Stem Cells consulted with Ms. Cunha, explaining the benefits of regenerative medicine and the positive implications it has had on treating and managing some of her symptoms. After the meeting, she quickly and comfortably made her decision to travel to China to receive stem cell therapy.

Blue Horizon Stem Cells is the division of Blue Horizon International (BHI) that provides stem cell therapy and research to achieve health benefits. Blue Horizon was founded by stem cell guru, Dr. Brian Mehling, an orthopedic trauma surgeon who believes advanced stem cell therapies will soon be preferred over many surgical, pharmacological, and rehabilitative medical services. Dr. Mehling’s Blue Horizon Charitable Foundation is the fundraising arm of his corporation that provides charity care for people who otherwise would not have access to these treatments. The foundation also supports charities promoting healthcare education and awareness across the globe.

“The trip to China exceeded my expectations,” said Ms. Cunha. “I met with Dr. Wu, director of the stem cell laboratory, the day after arriving in Wuhan. The hospital staff had all my records organized and after an initial consultation, my treatment was scheduled for the same day.”

After only two hours in the hospital, Ms. Cunha was released. “Everything went smoothly. I experienced no pain during the treatment. It was similar to receiving IV fluids.”

She was amazed by the results. “On the return trip to the United States, I felt very little pain during the entire 14-hour flight. Four weeks after the treatment, I was completely pain free.”

Ms. Cunha reports that her sleep habits have improved, she has returned to exercising, and best of all her productivity, both at work and at home has improved. “My life has changed dramatically,” she said.

Uniquely positioned to take advantage of its clinical research, BHSC has safely and efficiently treated more than 600 patients with over 2,600 regenerative procedures documenting each procedure while tracking the progress of patients through their treatment cycle. Blue Horizon International Stem Cell Therapy Program is associated with The Stem Cell Centre, Hongqiao Brain Hospital and Wuhan University School of Basic Medical Science, Wuhan, China. A new lab and treatment center for orthopedic therapies is scheduled to open at Medissimo Hospital and Clinic in May 2014. For more information, please visit www.bluehorizonstemcells.com.

Blue Horizon International is a healthcare consulting company with a unique concept that combines treatment, research, and philanthropic efforts. BHI provides the highest quality care and services available in surgical and medical treatments globally, the most advanced technologies currently available in stem cell therapies, and also provides resources needed to assist children and adults who are medically underserved. For more information, please visit www.bluehorizoninternational.com.

Read Full Story - Marina Cunha Remains Busy and Active After Traveling to China for Blue Horizon Stem Cell Treatments | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.